Covenant Research

Covenant Research is a private Florida-based clinical research and specialty care organization focused on liver and metabolic diseases. The organization appears to operate both as a patient-facing metabolic health clinic and as a clinical trial site, with emphasis on conditions such as metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction-associated steatohepatitis, primary biliary cholangitis, cirrhosis, diabetes, and obesity. Its current public-facing brand is Covenant Metabolic Specialists, while third-party directories and clinical trial listings also refer to Covenant Research and Covenant Research and Clinics. The company does not appear to develop its own drug pipeline; instead, it participates in sponsored clinical studies and provides diagnostics, monitoring, and specialty care services. Active trial examples associated with the site include studies involving volixibat and rencofilstat in cholestatic and fatty liver disease settings.